Shares of Covetrus Inc. (NASDAQ:CVET) traded today at $40.80, eclipsing its 52-week high. This new high was reached on below average trading volume as 121,000 shares traded hands, while the average 30-day volume is approximately 869,000 shares.
Covetrus Inc. share prices have moved between a 52-week high of $40.80 and a 52-week low of $4.04 and are now trading 900% above that low price at $40.47 per share.
Covetrus Inc is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. Its segments are North America, Europe, and APAC and Emerging Markets. The company’s services include supply chain services, software solutions, and prescription management.
Potential upside of 1,758.7% exists for Covetrus Inc., based on a current level of $40.47 and analysts’ average consensus price target of $752.20.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer